Table 5 Days in hospital for acute myeloid leukemia (AML) patients responding to treatment with valproic acid, all-trans retinoic acid (ATRA) and low-dose cytarabine
Patient | Overall survival (days) | Days in hospital relative to the total number of days: | |
|---|---|---|---|
From start of therapy to death | For the last 28 days before death | ||
CR1 | 296 | 59/ 296 | 0 |
CR2 | 383 | 42/ 383 | 8 |
SD1 | 102 | 18/ 102 | 14 |
SD2 | 419 | 20/ 419 | 6 |
SD3 | 171 | 54/ 171 | 4 |
SD4 | 151 | 93/ 151 | 23 |
SD5 | 239 | 80/ 239 | 18 |
SD6 | 147 | 35/ 147 | 2 |
SD7 | 132 | 41/ 132 | 4 |
SD8 | > 574 | 12/ > 574 | Still alive and living at home |
SD9 | > 141 | 12/ > 141 | Still alive and living at home |